Program 2020

17.00 – 17.30 – New concepts of immune checkpoint inhibitor treatment: is neoadjuvant therapy an option and why? – Univ. Prof. Dr. Christoph Zielinski

17.30-19.00 Breast cancer

17.30 – 18.00 – CDK4/6 in metastatic breast cancer – is it standard treatment for all metastatic ER+ patients? – Dr. Larisa Ciule

18.00 – 18.30 – Radiation therapy in breast conserving strategies – Conf. Dr. Laura Rebegea

18.30 – 19.00 – Escalating and deescalating neo/adjuvant treatment in Her2 + breast cancer– Dr Mircea Dediu

 

19.00– – 19.15 – BREAK

 

19.15 – 20.00 – Other gynecological cancers

19.15 – 19.35 – Ovarian cancer – what is new in 2020? – Sef de lucrări Dr. Oana Trifănescu

19.35 – 20.00 – Cervical cancer – radiation therapy in the modern era – Prof. Dr. Rodica Anghel

 

20.00 – 20.20 – Head and neck cancer

20.00 – 20.20 – Integrating IO in the head and neck cancer treatment – Conf. Dr. Laurenția Galeș

16:00 – 16:45 – Satellite Symposium BMS

16.00 – 16.15 –Opdivo + Yervoy, the new benchmark in the first line metastatic RCC – Dr. Daniela Zob

16.15 – 16.30 – Efficacy of Immunotherapy Regimen in the treatment of BRAF-mutant advanced melanoma – Conf. Dr. Laurentia Gales

16.30 – 16.45 – Opdivo®: a therapeutic strategy and a validated treatment algorithm for patients with metastatic NSCLC – Dr. Mircea Dediu

 

16:45 – 17:15 – Satellite Symposium Roche – New perspectives in oncology – 2020 Updates – Conf. Dr Laurenția Galeș

 

17.15-18.45 Prostate cancer

17.15 – 17.45 – PSA rising scenario – Dr. Mircea Dediu

17.45 – 18.15 – Radiation therapy in the rising PSA scenario – Prof. Dr. Gabriel Kacso

18.15 – 18.45 –Robotic Surgery in prostate cancer – Prim. Dr. Wolfgang Loidl

 

18.45 – 19.00 – BREAK

 

19.00 – 20.30 – Other genitourinary cancers

19.00 – 19.30 – Right sequence of therapy for metastatic RCC – Univ. Prof. Dr. Manuela Schmidinger

19.30 – 20.00 – The role of surgery in RCC – Prof. Dr. Viorel Jinga

20.00 – 20.25 – Defining the risk groups in testicular cancer – is adjuvant treatment necessary in early stages? – Prof. Dr. Lucian Miron

20.25 – 20.45 – Integrating IO in metastatic urotelial cancer – Dr. Luiza Șerbănescu

16:00 – 17:00 – Satellite Symposium Astra Zeneca

17.00-18.30 – Malignant melanoma

17.00 – 17.30 – Adjuvant treatment in malignant melanoma – Prof. Dr. Med. Dirk Schadendorf

17.30 – 18.00 – Standard surgery approach in localized melanoma – Prof. Dr. Ioan Lascăr

18.00 – 18.30 – IO or targeted therapy or both? in advanced malignant melanoma – Conf. Dr. Șerban Negru

 

18.30 – 18.45 – BREAK

 

20.00 – 21.30 – Molecular pathology and sarcoma

20.00 – 20.30 – Molecular pathology in soft tissue tumors – Univ. Prof. Dr. Bernadette Liegl-Atzwanger

20.30 – 21.00 – The role of radiation therapy in sarcoma – Dr. Mihai Georgescu

21.00 – 21.30 – Basic and principles of sarcoma treatment – Prof. Dr. Thomas Brodowicz

15:45 – 16:15 – Satellite Symposium Janssen –  How to identify the nmCRPC patients eligible for novel hormone therapies? – Conf. Dr. Laurentia Gales

 

16:15 – 17:00 – Satellite Symposium Pfizer

16:15 – 16:40 – Optimizing outcomes in ABC HR+/HER2- patients treatment: Clinical benefits of CDK4/6i class, real practice and patient-centric approach – Conf Dr Laurentia Nicoleta Gales

16:40 – 17:00 – Benefits of Lorviqua (lorlatinib) in ALK-positive NSCLC – Prof. Dr. Tudor Eliade Ciuleanu

 

17.00-18.30 Colon cancer

17.00 – 17.30 – Adjuvant setting – duration and type of chemotherapy – Dr. Răzvan Curcă

17.30 – 18.00 – Optimal Sequencing of treatment in MCRC (Chemo, BRAF, IO, VEGFR, EGFR) – Prof. Dr. Gerald Prager

18.00 – 18.30 –Correct surgical management of liver metastases in MCRC: when/why/how often – Univ. Prof. Dr. Klaus Kaczirek

 

18.30 – 18.45 – BREAK

 

18.45 – 20.15 – Lung cancer

18.45 – 19.15 – Update on first line immune therapy – Prof. Dr. Tudor Eliade Ciuleanu

19.15 – 19.45 – EGFR targeted treatment in Lung Cancer: Update State of the Art and Future Directions– Prof. Dr. Martin Filipits

19.45 – 20.15 – Radiation therapy and immunotherapy in stage III lung cancer – Asist. Univ. Dr. Radu Mitrică